New national guidelines say millions more Americans should get screened for lung cancer. The test can save lives, but it's inaccessible to many and harmful to some. How should we balance the promise and perils of lung cancer screening?
Guests:
Otis Brawley, MD, Professor of Oncology, Johns Hopkins University School of Medicine
Lisa Carter-Harris, PhD, APRN, Behavioral Scientist and Adult Nurse Practitioner, Memorial Sloan Kettering Cancer Center
Cherie Erkmen, MD, Professor of Thoracic Surgery and Director, Lung Cancer Screening Program, Temple University
Ella Kazerooni, MD, Professor of Radiology, University of Michigan
Ida Pittman, lung cancer patient, Temple University Hospital
Helena Price, Ida’s cousin and health care advocate
Gerard Silvestri, MD, Professor of Pulmonology, Medical University of South Carolina
Dig deeper into the research and tradeoffs of lung cancer screening on our website: https://tradeoffs.org/2021/05/27/catching-americas-top-cancer-killer/
Read a transcript of this episode: https://tradeoffs.org/2021/05/27/catching-americas-top-cancer-killer-transcript/
Sign up for our weekly newsletter to see what research health policy experts are reading right now, plus recommendations from our staff: bit.ly/tradeoffsnewsletter
Support this type of journalism today, with a gift: https://tradeoffs.org/donate
Follow us on Twitter: https://twitter.com/tradeoffspod
Hosted on Acast. See acast.com/privacy for more information.